Arrowhead Pharmaceuticals (ARWR)
(Delayed Data from NSDQ)
$24.88 USD
+0.21 (0.85%)
Updated May 24, 2024 04:00 PM ET
After-Market: $25.47 +0.59 (2.37%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMDetailed Estimates
EPS Estimates
Exp Earnings Date | 8/5/24 |
---|---|
Current Quarter | -0.58 |
EPS Last Quarter | -1.02 |
Last EPS Surprise | -1,600.00% |
ABR | 1.69 |
Earnings ESP
|
6.61% |
---|---|
Current Year | -3.05 |
Next Year | -2.71 |
EPS (TTM) | -4.25 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 67.43M | 106.43M | 129.66M | 230.32M |
# of Estimates | 4 | 6 | 8 | 7 |
High Estimate | 75.50M | 250.00M | 302.00M | 516.20M |
Low Estimate | 50.00M | 10.00M | 3.55M | 20.00M |
Year ago Sales | 15.83M | 16.10M | 240.74M | 129.66M |
Year over Year Growth Est. | 325.93% | 561.02% | -46.14% | 77.64% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.58 | -0.24 | -3.05 | -2.71 |
# of Estimates | 8 | 7 | 11 | 10 |
Most Recent Consensus | -0.64 | -0.95 | -3.14 | -2.61 |
High Estimate | -0.21 | 1.12 | -1.57 | -0.04 |
Low Estimate | -1.11 | -1.22 | -4.57 | -5.13 |
Year ago EPS | -0.96 | -1.03 | -1.92 | -3.05 |
Year over Year Growth Est. | 39.58% | 76.70% | -58.85% | 10.96% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 4 | 2 | 2 |
Up Last 60 Days | 3 | 4 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 2 | 8 | 7 |
Down Last 60 Days | 2 | 2 | 8 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Current | -0.58 | -0.24 | -3.05 | -2.71 |
7 Days Ago | -0.58 | -0.24 | -3.05 | -2.71 |
30 Days Ago | -0.64 | -0.53 | -2.70 | -2.53 |
60 Days Ago | -0.64 | -0.53 | -2.70 | -2.53 |
90 Days Ago | -0.64 | -0.53 | -2.70 | -2.53 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (9/2024) |
Next Year (9/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.54 | -0.20 | -3.08 | -2.82 |
Zacks Consensus Estimate | -0.58 | -0.24 | -3.05 | -2.71 |
Earnings ESP | 6.61% | 17.27% | -1.11% | -3.90% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.02 | -1.24 | -1.03 | -0.96 | NA |
Estimate | -0.06 | -0.78 | -0.70 | -0.58 | NA |
Difference | -0.96 | -0.46 | -0.33 | -0.38 | -0.53 |
Surprise | -1,600.00% | -58.97% | -47.14% | -65.52% | -442.91% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more